Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis.
Ontology highlight
ABSTRACT: Chronic hepatitis C may follow a mild and stable disease course or progress rapidly to cirrhosis and liver-related death. The mechanisms underlying the different rates of disease progression are unknown. Using serial, prospectively collected samples from cases of transfusion-associated hepatitis C, we identified outcome-specific features that predict long-term disease severity. Slowly progressing disease correlated with an early alanine aminotransferase peak and antibody seroconversion, transient control of viremia, and significant induction of IFN-γ and MIP-1β, all indicative of an effective, albeit insufficient, adaptive immune response. By contrast, rapidly progressive disease correlated with persistent and significant elevations of alanine aminotransferase and the profibrogenic chemoki
SUBMITTER: Farci P
PROVIDER: S-EPMC3437836 | biostudies-literature | 2012 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA